BTLA and ovarian carcinoma: Similar to PD-1 and CTLA-4, BTLA is an immune checkpoint associated with suppression of the immune response and its blockade has been related to a reduction of ovarian carcinoma via the regulation of IL6 and IL10 (69)⁠.